RYZNEUTA

What is this medication? RYZNEUTA is a prescription medicine used to decrease the risk of infection in adults with certain types of cancer who are receiving chemotherapy. Chemotherapy often causes a decrease in a specific type of white blood cell known as neutrophils, which are essential for fighting off bacterial infections. When these cell counts drop too low, a condition called febrile neutropenia can occur, making the patient highly susceptible to serious illness. By administering this medication, healthcare providers aim to maintain healthier immune levels throughout the course of anti-cancer treatments.

The medication works as a long-acting leukocyte growth factor that stimulates the bone marrow to produce more neutrophils. It is typically given as a subcutaneous injection after a chemotherapy session has been completed. By boosting the production of these vital white blood cells, RYZNEUTA helps the body strengthen its natural defenses against pathogens, thereby reducing the likelihood of hospitalizations or delays in cancer treatment due to infection.